Status:
COMPLETED
Restylane Perlane to Shape the Nasal Dorsum and/or Nasal Root
Lead Sponsor:
Galderma R&D
Conditions:
Nasal Augmentation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group
Eligibility Criteria
Inclusion
- Chinese origin
- Subject with desire to shape the nasal dorsum and/or nasal root
- Subjects who, in the opinion of the investigator, can achieve a clinically meaningful aesthetic correction of their nose with ≤ 1 ml Restylane Perlane
Exclusion
- Subjects with previous nasal surgery, including grafts or implants to the nose area
- Subjects requiring filler treatment around the tip of the nose or between the eyebrows (glabella region) to achieve a good aesthetic outcome
- Subjects with a history of chronic sinusitis or rhinitis
- Subjects who have previously received aesthetic treatment in the forehead, glabellar and/or nose area with a dermal filler
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT02216851
Start Date
September 1 2014
End Date
June 1 2016
Last Update
August 26 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing, China
2
Guangzhou, China